Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Alaibac

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Expert Opinion on Biological Therapy|August 23, 2017
Monoclonal antibodies against cutaneous T-cell lymphomasMauro Alaibac
Expert Opinion on Biological Therapy|December 19, 2018
Biological therapy of autoimmune blistering diseasesMauro Alaibac
Medicina (Kaunas, Lithuania)|October 28, 2023
Immune-Mediated Skin Diseases: Future Therapeutic PerspectivesMauro Alaibac
BMJ Case Reports|January 20, 2017
Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndromeElena Marinello, Stefano Piaserico, Mauro Alaibac
Experimental and Therapeutic Medicine|July 15, 2022
Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)Laura Gnesotto, Guido Mioso, Mauro Alaibac
In Vivo (Athens, Greece)|December 29, 2019
Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal CancerAlberto Meneguzzo, Annalisa Lazzarotto, Mauro Alaibac
Molecular and Clinical Oncology|November 17, 2017
Interaction between Merkel cell carcinoma and the immune system: Pathogenetic and therapeutic implicationsIrene Zanetti, Ilaria Coati, Mauro Alaibac
Immunotherapy|February 22, 2019
Recent advances in localized immunotherapy of skin cancersIrene Russo, Alvise Sernicola, Mauro Alaibac
Antibodies (Basel, Switzerland)|January 22, 2024
Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris?Christian Ciolfi, Jacopo Tartaglia, Mauro Alaibac
BMJ Case Reports|March 20, 2016
A case of psoriasis pustolosa palmaris induced by cetuximabElena Marinello, Davide Pastorelli, Mauro Alaibac
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Expert Opinion on Biological Therapy|August 23, 2017
Monoclonal antibodies against cutaneous T-cell lymphomasMauro Alaibac
Expert Opinion on Biological Therapy|December 19, 2018
Biological therapy of autoimmune blistering diseasesMauro Alaibac
Medicina (Kaunas, Lithuania)|October 28, 2023
Immune-Mediated Skin Diseases: Future Therapeutic PerspectivesMauro Alaibac
BMJ Case Reports|January 20, 2017
Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndromeElena Marinello, Stefano Piaserico, Mauro Alaibac
Experimental and Therapeutic Medicine|July 15, 2022
Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)Laura Gnesotto, Guido Mioso, Mauro Alaibac
In Vivo (Athens, Greece)|December 29, 2019
Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal CancerAlberto Meneguzzo, Annalisa Lazzarotto, Mauro Alaibac
Molecular and Clinical Oncology|November 17, 2017
Interaction between Merkel cell carcinoma and the immune system: Pathogenetic and therapeutic implicationsIrene Zanetti, Ilaria Coati, Mauro Alaibac
Immunotherapy|February 22, 2019
Recent advances in localized immunotherapy of skin cancersIrene Russo, Alvise Sernicola, Mauro Alaibac
Antibodies (Basel, Switzerland)|January 22, 2024
Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris?Christian Ciolfi, Jacopo Tartaglia, Mauro Alaibac
BMJ Case Reports|March 20, 2016
A case of psoriasis pustolosa palmaris induced by cetuximabElena Marinello, Davide Pastorelli, Mauro Alaibac
Pageof 15